Correction: MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene

Related Experiment Video

Updated: Feb 22, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.6K

Youguang Pu, Fangfang Zhao, Haiyan Wang

    Oncotarget
    |September 27, 2017
    PubMed

    Insights

    This study corrects a previous article DOI. The correction ensures accurate referencing for scientific research and aids in the retrieval of important oncological findings.

    Area of Science:

    • Correction of scientific literature
    • Ensuring accurate citation of research

    Context:

    • Previous article DOI was incorrect
    • Accurate referencing is crucial in scientific publishing

    Purpose:

    • To provide the correct DOI for the article
    • To maintain the integrity of scientific records

    Summary:

    • The article DOI 10.18632/oncotarget.8546 has been corrected.
    • This ensures proper attribution and access to the published research.

    Impact:

    • Facilitates accurate citation and retrieval of the article
    • Upholds scientific record-keeping standards
    • Supports the broader scientific community's access to information

    More Related Videos

    Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study02:35

    Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

    Published on: March 22, 2024

    1.6K
    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    3.3K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.0K
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.8K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    4.9K
    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
    6.7K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    5.3K